Time to first decision with review:
Time from acceptance to publication:
Aims and scope
Open Heart is an online-only, open access cardiology journal that aims to be "open" in many ways: open access (free access for all readers), open peer review (unblinded peer review) and open data (data sharing is encouraged). The goal is to ensure maximum transparency and maximum impact on research progress and patient care. The journal is dedicated to publishing high quality, peer reviewed medical research in all disciplines and therapeutic areas of cardiovascular medicine. Research is published across all study phases and designs, from study protocols to phase I trials to meta-analyses, including small or specialist studies. Opinionated discussions on controversial topics are welcomed.
Open Heart aims to operate a fast submission and review process with continuous publication online, to ensure timely, up-to-date research is available worldwide. The journal adheres to a rigorous and transparent peer review process, and all articles go through a statistical assessment to ensure robustness of the analyses. Open Heart is an official journal of the British Cardiovascular Society.
For information about the Open Heart Editor-in-Chief Pascal Meier and his editorial team, please refer to the Editorial Board page.
Open Heart is co-owned by the British Cardiovascular Society and BMJ.
Continuous online publication
Web of Science Core Collection: Emerging Sources Citation Index, Medline, PubMed Central, Scopus, Embase (Excerpta Medica), DOAJ, Google Scholar
Peer review model
Single blind; the names of reviewers are hidden from the author
Acceptance rate: 59%
Speed Time to first decision without review (median): 20 days Time to first decision with review (median): 41 days Time from acceptance to publication (median): 15 days
Impact Citescore: 3.7 Citescore rank: 135/336 Scimago Journal Rank (SJR): 0.911
Reach 2021 total content views: 631,363 2021 total Altmetric mentions: 3,099
The impact that academic research has cannot be defined by one single metric. In 2013, BMJ signed the San Francisco Declaration on Research Assessment (DORA). We did this to show our support for using multiple measures and metrics to portray journals’ impact; moving away from the Impact Factor as a single measure. How we get these metrics
For all contact information please refer to the contact us page.
Please refer to the instructions for authors
Rights and Permissions
The BMJ Publishing Group is a founding member of COPE (the Committee on Publication Ethics), which provides a forum for publishers and Editors of scientific journals to discuss issues relating to the integrity of the work submitted to or published in their journals.
The EQUATOR Network is an international initiative that seeks to improve the value of medical research literature by promoting accurate, transparent reporting of research studies. The BMJ Publishing Group is a sponsor of its activities.